Enterprise Value
51.65M
Cash
111.5M
Avg Qtr Burn
-6.897M
Short % of Float
0.78%
Insider Ownership
1.62%
Institutional Own.
90.14%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CTI-1601 Details Rare diseases, Rare genetic disease, Pain, Friedreich’s Ataxia | Phase 2 Update |